Protocol of the Fit-For-Fertility study: a multicentre randomised controlled trial assessing a lifestyle programme targeting women with obesity and infertility.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
19 04 2022
Historique:
entrez: 20 4 2022
pubmed: 21 4 2022
medline: 22 4 2022
Statut: epublish

Résumé

Women with obesity are at a higher risk of infertility as well as gestational and neonatal complications. Lifestyle changes are universally recommended for women with obesity seeking fertility treatments, but such intervention has only been assessed in very few robust studies. This study's objectives are therefore to assess the clinical outcomes and cost-effectiveness of an interdisciplinary lifestyle intervention (the Fit-For-Fertility Programme; FFFP) targeting women with obesity and subfertility in a diverse population. This pragmatic multicentre randomised controlled trial (RCT) will include 616 women with obesity (body mass index ≥30 kg/m This research study has been approved by the Research Ethics Board (REB) of NCT03908099. 1.1, 13 April 2019.

Identifiants

pubmed: 35440463
pii: bmjopen-2022-061554
doi: 10.1136/bmjopen-2022-061554
pmc: PMC9020282
doi:

Banques de données

ClinicalTrials.gov
['NCT03908099']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e061554

Investigateurs

R Bouzayen (R)
N Chaillet (N)
W Fraser (W)
F Gallagher (F)
A Godbout (A)
E Greenblatt (E)
C Kamga-Ngande (C)
Kong Weilin (K)
S Laredo (S)
M Sagle (M)
B Taylor (B)

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: Ferring has provided an unrestricted grant for the trial, without influencing the design or conduct of the trial, or the analysis or dissemination of the study’s results.

Références

N Engl J Med. 2017 Nov 30;377(22):2145-2153
pubmed: 29171811
Exp Diabetes Res. 2011;2011:596060
pubmed: 22110473
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Obesity (Silver Spring). 2013 Mar;21(3):E236-43
pubmed: 23404845
Trends Endocrinol Metab. 2015 Feb;26(2):84-90
pubmed: 25523615
Diabetes Metab. 2011 Nov;37(5):410-8
pubmed: 21489843
BMC Obes. 2014 Sep 03;1:19
pubmed: 26217506
Reprod Biomed Online. 2017 Oct;35(4):453-460
pubmed: 28688924
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
CMAJ. 2007 Apr 10;176(8):S1-13
pubmed: 17420481
Clin Obes. 2015 Apr;5(2):67-71
pubmed: 25735259
CMAJ. 2020 Aug 4;192(31):E875-E891
pubmed: 32753461
Value Health. 2019 Jul;22(7):837-842
pubmed: 31277832
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Am J Obstet Gynecol. 2004 Apr;190(4):1091-7
pubmed: 15118648
Lancet. 2018 May 5;391(10132):1842-1852
pubmed: 29673874
Metab Syndr Relat Disord. 2010 Oct;8(5):437-41
pubmed: 20715934
Obes Res. 2002 Jun;10(6):551-4
pubmed: 12055331
Clin Obes. 2016 Aug;6(4):243-8
pubmed: 27242175
J Am Diet Assoc. 2009 May;109(5):918-27
pubmed: 19412993
JMIR Mhealth Uhealth. 2018 Aug 09;6(8):e10527
pubmed: 30093371
J Clin Endocrinol Metab. 2016 Jul;101(7):2658-66
pubmed: 27172435
BMC Health Serv Res. 2007 Oct 10;7:163
pubmed: 17927835
Obes Rev. 2019 Apr;20(4):510-526
pubmed: 30549166
Health Rep. 2012 Sep;23(3):53-60
pubmed: 23061265
Reprod Med Biol. 2013 Jun 11;12(4):151-158
pubmed: 29699141
Metab Syndr Relat Disord. 2009 Aug;7(4):297-304
pubmed: 19558274
Hum Reprod. 2017 Jul 1;32(7):1418-1426
pubmed: 28486704
Semin Reprod Med. 2018 May;36(3-04):221-232
pubmed: 30866009
J Clin Endocrinol Metab. 1999 May;84(5):1617-22
pubmed: 10323389
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Curr Opin Obstet Gynecol. 2009 Dec;21(6):521-6
pubmed: 19809317
Med Care. 2020 Jun;58(6):566-573
pubmed: 32221100
Hum Reprod. 2008 Feb;23(2):324-8
pubmed: 18077317
Hum Reprod. 2012 Mar;27(3):738-46
pubmed: 22258658
Health Serv Res. 2008 Feb;43(1 Pt 1):96-116
pubmed: 18211520
Sleep Med Rev. 2016 Feb;25:52-73
pubmed: 26163057
N Engl J Med. 2018 Oct 04;379(14):1303-1312
pubmed: 30281992
PLoS One. 2018 Nov 7;13(11):e0206888
pubmed: 30403756
Int J Environ Res Public Health. 2012 Apr;9(4):1263-307
pubmed: 22690193
Hum Reprod Update. 2003 Sep-Oct;9(5):429-49
pubmed: 14640376
Br J Obstet Gynaecol. 1992 Feb;99(2):128-31
pubmed: 1554664
Int J Gynaecol Obstet. 2009 Jan;104(1):53-5
pubmed: 18957271
Hum Reprod. 2007 Jun;22(6):1634-7
pubmed: 17344224
Fertil Steril. 2011 Aug;96(2):409-415.e3
pubmed: 21458806
Hum Reprod. 2017 Sep 1;32(9):1786-1801
pubmed: 29117321
Hum Reprod. 2010 Mar;25(3):578-83
pubmed: 20085914
Hum Fertil (Camb). 2007 Dec;10(4):195-206
pubmed: 18049955
Matern Child Health J. 2009 Sep;13(5):614-20
pubmed: 18618231
Hum Reprod Update. 2007 Sep-Oct;13(5):433-44
pubmed: 17584821
J Obstet Gynaecol Can. 2018 Jul;40(7):950-966
pubmed: 29921431
Obstet Gynecol. 2004 Feb;103(2):219-24
pubmed: 14754687
Fertil Steril. 2006 Sep;86(3):642-6
pubmed: 16782095
Eur J Clin Nutr. 2012 Feb;66(2):166-73
pubmed: 21934698
N Engl J Med. 2016 May 19;374(20):1942-53
pubmed: 27192672
Med Clin North Am. 2008 Sep;92(5):1163-92, xi
pubmed: 18721657
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Occup Med (Lond). 2014 Jul;64(5):393-4
pubmed: 25005549
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
BMC Obes. 2015 Dec 01;2:47
pubmed: 26635965
Value Health. 2005 Sep-Oct;8(5):521-33
pubmed: 16176491
Transl Behav Med. 2021 Mar 16;11(2):642-652
pubmed: 32145022
Hum Reprod. 2010 Jan;25(1):118-26
pubmed: 19855108
BMJ. 2015 May 08;350:h2147
pubmed: 25956159

Auteurs

Matea Belan (M)

Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Research Center of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.

Myriam Gélinas (M)

Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Belina Carranza-Mamane (B)

Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Department of Obstetrics and Gynecology, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Marie-France Langlois (MF)

Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Research Center of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.

Anne-Sophie Morisset (AS)

School of Nutrition, Faculty of Agricultural and Food Science, Laval University, Quebec city, Quebec, Canada.

Stephanie-May Ruchat (SM)

Department of Human Kinetics, Université du Quebec à Trois-Rivières, Trois-Rivières, Quebec, Canada.

Kim Lavoie (K)

Research Center CIUSSS-NIM, Montreal Behavioural Medicine Centre, Montreal, Quebec, Canada.
Department of Psychology, Université du Québec a Montréal, Montréal, Quebec, Canada.

Kristi Adamo (K)

Faculty of Health Sciences, School of Human Kinetics, University of Ottawa, Ottawa, Ontario, Canada.

Thomas Poder (T)

School of Public Health, University of Montreal, Montreal, Quebec, Canada.
CIUSSS de l'Est de l'Île de Montréal, Centre de recherche de l'Institut universitaire en santé mentale de Montréal, Montreal, Quebec, Canada.

Frances Gallagher (F)

School of Nursing, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Marie-Hélène Pesant (MH)

Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Research Center of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.

Farrah Jean-Denis (F)

Research Center of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.

Jean-Patrice Baillargeon (JP)

Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, Quebec, Canada Jean-Patrice.Baillargeon@USherbrooke.ca.
Research Center of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH